Advertisement

Topics

Proteostasis Therapeutics Announces Withdrawal of Equity Offering Due to Market Conditions

19:59 EDT 20 Mar 2018 | BioMedReports - Blog

About Proteostasis Therapeutics, Inc.

Proteostasis Therapeutics, Inc. is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis (CF) and other diseases

Read more...

Original Article: Proteostasis Therapeutics Announces Withdrawal of Equity Offering Due to Market Conditions

NEXT ARTICLE

More From BioPortfolio on "Proteostasis Therapeutics Announces Withdrawal of Equity Offering Due to Market Conditions"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Pulmonary
Pulmonary relating to or associated with the lungs eg Asthma, chronic bronchitis, emphysema, COPD, Cystic Fibrosis, Influenza,  Lung Cancer, Pneumonia, Pulmonary Arterial Hypertension, Sleep Disorders etc Follow and track Lung Cancer News ...